Activation of TLX3 and NKX2-5 in T(5;14)(Q35;Q32) T-Cell Acute Lymphoblastic Leukemia by Remote 3¶-BCL11B Enhancers and Coregulation by PU.1 and HMGA1

Total Page:16

File Type:pdf, Size:1020Kb

Activation of TLX3 and NKX2-5 in T(5;14)(Q35;Q32) T-Cell Acute Lymphoblastic Leukemia by Remote 3¶-BCL11B Enhancers and Coregulation by PU.1 and HMGA1 Research Article Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-Cell Acute Lymphoblastic Leukemia by Remote 3¶-BCL11B Enhancers and Coregulation by PU.1 and HMGA1 Stefan Nagel,1 Michaela Scherr,2 Alexander Kel,3 Klaus Hornischer,3 Gregory E. Crawford,4 Maren Kaufmann,1 Corinna Meyer,1 Hans G. Drexler,1 and Roderick A.F. MacLeod1 1Deutsche Sammlung von Mikroorganismen und Zellkulturen (German Collection of Microorganisms and Cell Cultures), Department of Cell Cultures, Braunschweig, Germany; 2Department of Hematology, Hemostasis and Oncology, Hanover Medical School, Hanover, Germany; 3BIOBASE GmbH, Wolfenbu¨ttel, Germany; and 4Duke University, Institute for Genome Sciences and Policy, Durham, North Carolina Abstract Introduction In T-cell acute lymphoblastic leukemia, alternative t(5;14)- BCL11B (also known as CTIP2/Rit1) is a Kru¨ppel familyzinc (q35;q32.2) forms effect dysregulation of either TLX3 or finger gene located at 14q32, which is expressed during thymocyte À À NKX2-5 homeobox genes at 5q35 by juxtaposition with maturation from CD4 /CD8 to CD4+/CD8+ stages (1). BCL11B 14q32.2 breakpoints dispersed across the BCL11B downstream mayact either as a tumor-suppressor gene, first detected via genomic desert.Leukemic gene dysregulation by t(5;14) was inactivating mutations or deletions in murine radiation-induced investigated by DNA inhibitory treatments with 26-mer lymphomas (2) and more recently in T-cell acute lymphoblastic double-stranded DNA oligonucleotides directed against can- leukemia (T-cell ALL; ref. 3); or, as an oncogenic activator, first didate enhancers at, or near, orphan T-cell DNase I hypersen- detected byits juxtaposition with the TLX3 (also known as sitive sites located between 3¶-BCL11B and VRK1. NKX2-5 HOX11L2) homeobox gene at 5q35 via the recurrent t(5;14) down-regulation in t(5;14) PEER cells was almost entirely (q35;q32) rearrangement also in T-cell ALL (4–6). A neighboring restricted to DNA inhibitory treatment targeting enhancers related homeobox gene, NKX2-5 (also known as CSX), is similarly within the distal breakpoint cluster region and was dose and activated in T-cell ALL bya variant t(5;14)(q35;q32) or by sequence dependent, whereas enhancers near 3¶-BCL11B t(5;14)(q35;q11.2) involving the T-cell receptor D locus at 14q11.2 regulated that gene only.Chromatin immunoprecipitation (7, 8). Recently, interleukin-2 has been identified as a transcrip- assays showed that the four most effectual NKX2-5 ectopic tional target of BCL11B in both developing and transformed T enhancers were hyperacetylated.These enhancers clustered cells (9). The ectopic expression of Nirenberg-Kim family f1 Mbp downstream of BCL11B, within a region displaying homeobox genes (e.g., TLX3) has been recentlyshown to drive multiple regulatory stigmata, including a TCRA enhancer proliferation of myeloid progenitor cells in a mouse model (10). motif, deep sequence conservation, and tight nuclear matrix Nevertheless, the mechanism underlying leukemic deregulation by attachment relaxed by trichostatin A treatment.Intriguingly, t(5;14) remains obscure, mainlybecause 14q32.2 breakpoints are although TLX3/NKX2-5 promoter/exon 1 regions were hypo- widelyscattered over the f1 Mbp downstream breakpoint cluster acetylated, their expression was trichostatin A sensitive, region. Analogies with T-cell receptor loci and the nature of the implying extrinsic regulation by factor(s) under acetylation ‘‘genomic desert’’ covering 3¶-BCL11B support the existence of PU.1 control.Knockdown of , known to be trichostatin A underlying interactions between TLX3/NKX2-5 and remote TLX3 NKX2-5 responsive and which potentially binds / pro- transcriptional enhancers. moters, effected down-regulation of both homeobox genes. Chromosomal mechanisms governing remote transcriptional Moreover, genomic analysis showed preferential enrichment regulation have latelyattracted increasing interest. In particular, near ectopic enhancers of binding sites for the PU.1 cofactor conserved noncoding elements/regions/sequences identified near NKX2-5 HMGA1, the knockdown of which also inhibited .We metazoan developmental genes show coordinate enhancer activity suggest that HMGA1 and PU.1 coregulate ectopic homeobox when tested in zebrafish embryos (11). Physical juxtaposition gene expression in t(5;14) T-cell acute lymphoblastic leukemia between regulators and their targets has now been shown (12). by interactions mediated at the nuclear matrix.Our data These interactions are believed to occur at chromatin loops tethered document homeobox gene dysregulation by a novel regulatory to nuclear scaffold matrix attachment regions (13–15). DNaseI ¶ BCL11B region at 3 - responsive to histone deacetylase inhibi- hypersensitive sites denote ‘‘active’’ chromatin and are believed to tion and highlight a novel class of potential therapeutic target heighten the accessibilityof nucleosome-depleted regulatoryDNA amid noncoding DNA. [Cancer Res 2007;67(4):1461–71] regions and facilitate loading of transcription factor binding sites. Chromatin relaxation is also associated with histone hyperacetyla- tion (16) and is antagonized byhistone deacetylases.A global survey of regulatoryregions in CD4 + T cells uncovered >5,000 DNaseI Note: Supplementarydata for this article are available at Cancer Research Online hypersensitive sites mostly bracketing active genes (17). A notable (http://cancerres.aacrjournals.org/). exception included an orphan DNaseI hypersensitive site cluster Requests for reprints: Roderick A.F. MacLeod or Stefan Nagel, Deutsche Sammlung von Mikroorganismen und Zellkulturen, Department of Cell Cultures, lying inside the BCL11B gene desert amid a region subsequently Inhoffenstrasse 7B, 38124 Braunschweig, Germany. Phone: 49-531-261-6167; Fax: 49- shown to host an acetylation island in T cells (18). 531-261-6150; E-mail: [email protected] or [email protected]. ¶ I2007 American Association for Cancer Research. To investigate the role of 3 -BCL11B in leukemic cis-activation, doi:10.1158/0008-5472.CAN-06-2615 we adapted DNA inhibitorytreatments byusing matching www.aacrjournals.org 1461 Cancer Res2007; 67: (4). February 15, 2007 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2007 American Association for Cancer Research. Cancer Research oligonucleotides directed against specific noncoding sequences Chromatin immunoprecipitation assay. Chromatin immunoprecipi- based on previous work on the IgH enhancer (19, 20). Regulatory tation (ChIP) was done as recommended using the ChIP Assaykit (Upstate), 6 potential was further analyzed via nuclear matrix attachment in whereby10 cells were sonicated for 30 seconds, producing fragments A nuclear halo preparations, and bycharacterizing protein acetyla- ranging 100 to 1,000 bp, and precipitated with 10 g of the anti–acetyl- histone H3 antibody. For PCR analysis, 400 ng of DNA (ChIP or complete tion associated with both genes and noncoding regions. Binding genomic DNA) were used as templates (SupplementaryTable S1). site matrices for transcription factors PU.1 and HMGA1, identified PCR. Total RNA was isolated 6 or 24 h after trichostatin A treatment, in the promoter regions of TLX3 and near regulatoryDNaseI either 24 h after electroporation with the individual oligonucleotides, or 4 to hypersensitive sites, respectively, by using the TRANSFAC database 5 days after lentiviral transduction. RNA extraction, cDNA synthesis, and (21) were targeted for inhibition bysmall interfering RNA (siRNA) PCR were done as described previously(7). Real-time quantitative-PCR (RQ- treatment, and their effects on leukemic homeobox gene PCR) was done as described previously(28). Oligonucleotide sequences are expression in t(5;14) cells were measured. listed in SupplementaryTable S1. Our data support the existence of a remote regulatoryDNaseI Oligonucleotide inhibitory treatments. Transient inhibitorytreat- hypersensitive site cluster associated with leukemic homeobox ments were modified from that described byCutrona et al. (20), substituting gene activation in t(5;14) T-cell ALL. TRANSFAC data show this double-stranded 26-mer double-stranded oligonucleotide (DSO) phosphor- othioate modified at positions 1-2/25-26 (purchased from MWG) for peptide putative regulatoryenhancer region to be enriched in HMGA1 nucleic acid oligonucleotides. In 10 of 16 cases, DSO sequences (Table 1) binding sites juxtaposed bypartner PU.1 sites at promoter regions were uniquelylocated at, or near ( V1 kbp), orphan T-cell DNaseI of both TLX3 and NKX2-5. We propose that leukemic activation hypersensitive sites (17), whereas the remainder lay either offset by f1 overlays HMGA1-PU.1 interactions mediated cytogenetically by to 10 kbp (DSO.12-14), or remote by>10 kbp (DSO.3/5), from DNaseI transcription factor binding site juxtaposition, highlighting the hypersensitive sites. Target sequences were chosen using TRANSFAC role of noncoding DNA in neoplasia and as a potential therapeutic databanks listing paired transcription factor binding sites displaced by target therein. <10 bp (the so-called composite elements; ref. 21). The selection process is shown in SupplementaryFig. S1 A for DSO.6. DSOs were produced by pooling equimolar amounts of complementarysingle-stranded oligonucleo- tides dissolved in water, heating to 95jC for 5 min and incubating at room Materialsand Methods temperature for 30 min. For electroporation, 2 Ag pEGFP-N1 reporter Cells and culture. Detailed descriptions of cell lines and culture (Clontech, Heidelberg, Germany) or DSO (20 Amol/L) were used to treat 106 methods
Recommended publications
  • Tlx3 Exerts Direct Control in Specifying Excitatory Over Inhibitory Neurons in the Dorsal Spinal Cord
    fcell-09-642697 April 24, 2021 Time: 18:18 # 1 ORIGINAL RESEARCH published: 29 April 2021 doi: 10.3389/fcell.2021.642697 Tlx3 Exerts Direct Control in Specifying Excitatory Over Inhibitory Neurons in the Dorsal Spinal Cord Filipe A. Monteiro1,2,3*, Rafael M. Miranda1,2,3, Marta C. Samina1,2,3, Ana F. Dias2,3,4, Alexandre A. S. F. Raposo5,6, Patrícia Oliveira3,7, Carlos Reguenga1,2,3, Diogo S. Castro3,5,8† and Deolinda Lima1,2,3† 1 Unidade de Biologia Experimental, Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, Porto, Portugal, 2 Pain Research Group, Instituto de Biologia Molecular e Celular, Porto, Portugal, 3 Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, 4 Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal, 5 Molecular Neurobiology Group, Instituto Gulbenkian de Ciência, Oeiras, Portugal, 6 Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal, 7 Diagnostics, Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal, 8 Stem Cells & Neurogenesis Group, Instituto de Biologia Molecular e Celular, Porto, Portugal The spinal cord dorsal horn is a major station for integration and relay of somatosensory information and comprises both excitatory and inhibitory neuronal populations. The homeobox gene Tlx3 acts as a selector gene to control the development of late- Edited by: Jiri Novotny, born excitatory (dILB) neurons by specifying glutamatergic transmitter fate in dorsal Charles University, Czechia spinal cord. However, since Tlx3 direct transcriptional targets remain largely unknown, Reviewed by: it remains to be uncovered how Tlx3 functions to promote excitatory cell fate.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Depletion of Kcnq1ot1 Non-Coding RNA Does Not Affect Imprinting Maintenance in Stem Cells Michael C
    DEVELOPMENT AND STEM CELLS RESEARCH ARTICLE 3667 Development 138, 3667-3678 (2011) doi:10.1242/dev.057778 © 2011. Published by The Company of Biologists Ltd Depletion of Kcnq1ot1 non-coding RNA does not affect imprinting maintenance in stem cells Michael C. Golding1,2,3,*,†, Lauren S. Magri1,2,3,†, Liyue Zhang2,3, Sarah A. Lalone1,2,3, Michael J. Higgins4 and Mellissa R. W. Mann1,2,3,‡ SUMMARY To understand the complex regulation of genomic imprinting it is important to determine how early embryos establish imprinted gene expression across large chromosomal domains. Long non-coding RNAs (ncRNAs) have been associated with the regulation of imprinting domains, yet their function remains undefined. Here, we investigated the mouse Kcnq1ot1 ncRNA and its role in imprinted gene regulation during preimplantation development by utilizing mouse embryonic and extra-embryonic stem cell models. Our findings demonstrate that the Kcnq1ot1 ncRNA extends 471 kb from the transcription start site. This is significant as it raises the possibility that transcription through downstream genes might play a role in their silencing, including Th, which we demonstrate possesses maternal-specific expression during early development. To distinguish between a functional role for the transcript and properties inherent to transcription of long ncRNAs, we employed RNA interference-based technology to deplete Kcnq1ot1 transcripts. We hypothesized that post-transcriptional depletion of Kcnq1ot1 ncRNA would lead to activation of normally maternal-specific protein-coding genes on the paternal chromosome. Post-transcriptional short hairpin RNA-mediated depletion in embryonic stem, trophoblast stem and extra-embryonic endoderm stem cells had no observable effect on the imprinted expression of genes within the domain, or on Kcnq1ot1 imprinting center DNA methylation, although a significant decrease in Kcnq1ot1 RNA signal volume in the nucleus was observed.
    [Show full text]
  • Regulation of Bcl11b by Post-Translational Modifications
    AN ABSTRACT OF THE THESIS OF Xiao Liu for the degree of Master of Science in Pharmacy presented on June 3, 2011. Title: REGULATION OF BCL11B BY POST-TRANSLATIONAL MODIFICATIONS. Abstract approved Mark E. Leid Bcl11b (B-cell lymphoma/leukemia 11b), also known as Ctip2 (Chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2), is a C2H2 zinc finger transcriptional regulatory protein, which is an essential protein for post-natal life in the mouse and plays crucial roles in the development, and presumably function, of several organ systems, including the central nervous, immune, craniofacial formation and cutaneous/skin systems. Moreover, inactivation of Bcl11b has been implicated in the etiology of lymphoid malignancies, suggesting that Bcl11b may function as a tumor suppressor. Bcl11b was originally identified as a protein that interacted directly with the orphan nuclear receptor COUP-TF2. Later studies revealed that this C2H2 zinc finger protein can bind DNA directly in a COUP-independent manner, and it has been studied mostly as a transcription repressor. In T cells, gene repression mediated by Bcl11b involves the recruitment of class I HDACs, HDAC1 and HDAC2, within the context of the Nucleosome Remodeling and Deacetylation (NuRD) complex. The hypothesis that Bcl11b functions as a transcriptional repressor has been supported by transcriptome analyses in mouse T cells and human neuroblastoma cells. However, approximately one- third of the genes that were dysregulated in the double positive (DP) cells of Bcl11b-null mice were down-regulated relative to control T cells, suggesting that Bcl11b may act as a transcriptional activator in some promoter and/or cell contexts.
    [Show full text]
  • INTRODUCTION Sirna and Rnai
    J Korean Med Sci 2003; 18: 309-18 Copyright The Korean Academy ISSN 1011-8934 of Medical Sciences RNA interference (RNAi) is the sequence-specific gene silencing induced by dou- ble-stranded RNA (dsRNA). Being a highly specific and efficient knockdown tech- nique, RNAi not only provides a powerful tool for functional genomics but also holds Institute of Molecular Biology and Genetics and School of Biological Science, Seoul National a promise for gene therapy. The key player in RNAi is small RNA (~22-nt) termed University, Seoul, Korea siRNA. Small RNAs are involved not only in RNAi but also in basic cellular pro- cesses, such as developmental control and heterochromatin formation. The inter- Received : 19 May 2003 esting biology as well as the remarkable technical value has been drawing wide- Accepted : 23 May 2003 spread attention to this exciting new field. V. Narry Kim, D.Phil. Institute of Molecular Biology and Genetics and School of Biological Science, Seoul National University, San 56-1, Shillim-dong, Gwanak-gu, Seoul 151-742, Korea Key Words : RNA Interference (RNAi); RNA, Small interfering (siRNA); MicroRNAs (miRNA); Small Tel : +82.2-887-8734, Fax : +82.2-875-0907 hairpin RNA (shRNA); mRNA degradation; Translation; Functional genomics; Gene therapy E-mail : [email protected] INTRODUCTION established yet, testing 3-4 candidates are usually sufficient to find effective molecules. Technical expertise accumulated The RNA interference (RNAi) pathway was originally re- in the field of antisense oligonucleotide and ribozyme is now cognized in Caenorhabditis elegans as a response to double- being quickly applied to RNAi, rapidly improving RNAi stranded RNA (dsRNA) leading to sequence-specific gene techniques.
    [Show full text]
  • Structural and Spatial Chromatin Features at Developmental Gene Loci in Human Pluripotent Stem Cells
    ARTICLE DOI: 10.1038/s41467-017-01679-x OPEN Structural and spatial chromatin features at developmental gene loci in human pluripotent stem cells Hiroki Ikeda1, Masamitsu Sone1,2, Shinya Yamanaka1,3 & Takuya Yamamoto 1,2,4 Higher-order chromatin organization controls transcriptional programs that govern cell properties and functions. In order for pluripotent stem cells (PSCs) to appropriately respond 1234567890 to differentiation signals, developmental gene loci should be structurally and spatially regu- lated to be readily available for immediate transcription, even though these genes are hardly expressed in PSCs. Here, we show that both chromatin interaction profiles and nuclear positions at developmental gene loci differ between human somatic cells and hPSCs, and that changes in the chromatin interactions are closely related to the nuclear repositioning. Moreover, we also demonstrate that developmental gene loci, which have bivalent histone modifications, tend to colocalize in PSCs. Furthermore, this colocalization requires PRC1, PRC2, and TrxG complexes, which are essential regulatory factors for the maintenance of transcriptionally poised developmental genes. Our results indicate that higher-order chro- matin regulation may be an integral part of the differentiation capacity that defines pluripotency. 1 Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan. 2 Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan. 3 Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA. 4 AMED-CREST, AMED 1-7-1 Otemach, Chiyodaku, Tokyo 100-0004, Japan. Correspondence and requests for materials should be addressed to T.Y.
    [Show full text]
  • Genequery™ Human Stem Cell Transcription Factors Qpcr Array
    GeneQuery™ Human Stem Cell Transcription Factors qPCR Array Kit (GQH-SCT) Catalog #GK125 Product Description ScienCell's GeneQuery™ Human Stem Cell Transcription Factors qPCR Array Kit (GQH-SCT) surveys a panel of 88 transcription factors related to stem cell maintenance and differentiation. Transcription factors are proteins that can regulate target gene transcription level by binding to specific regions of the genome known as enhancers or silencers. Brief examples of how genes may be grouped according to their functions are shown below: • Pluripotency transcription factors: NANOG, POU5F1, SOX2 • Embryonic development: EOMES, FOXC2/D3/O1, HOXA9/A10, KLF2/5, LIN28B, MAX, PITX2, SMAD1, TBX5, ZIC1 • Germ layer formation and differentiation: FOXA2, GATA6, HAND1, ISL1, KLF4, SMAD2, SOX9 • Organ morphogenesis: EZH2, HOXA11/B3/B5/C9, MSX2, MYC, PAX5/8, VDR • Angiogenesis: CDX2, JUN, NR2F2, RUNX1, WT1 • Hematopoiesis and osteogenesis: EGR3, ESR1, GATA1/2/3, GLI2, NFATC1, PAX9, RB1, SOX6, SP1, STAT1 • Neural stem cell maintenance and differentiation: ATF2, CREB1, FOSB, FOXO3, HES1, HOXD10, MCM2/7, MEF2C, NEUROD1/G1, OLIG1/2, PAX3/6, POU4F1, PPARG, SMAD3/4, SNAI1, STAT3 Note : all gene names follow their official symbols by the Human Genome Organization Gene Nomenclature Committee (HGNC). GeneQuery™ qPCR array kits are qPCR ready in a 96-well plate format, with each well containing one primer set that can specifically recognize and efficiently amplify a target gene's cDNA. The carefully designed primers ensure that: (i) the optimal annealing temperature in qPCR analysis is 65°C (with 2 mM Mg 2+ , and no DMSO); (ii) the primer set recognizes all known transcript variants of target gene, unless otherwise indicated; and (iii) only one gene is amplified.
    [Show full text]
  • The Role of Nkx2.5 in Keratinocyte Differentiation
    Ann Dermatol Vol. 21, No. 4, 2009 ORIGINAL ARTICLE The Role of Nkx2.5 in Keratinocyte Differentiation Chul Hwang, M.D., Sunhyae Jang, M.S., Dae Kyoung Choi, M.S., Sujong Kim, Ph.D.1, Joong Hwa Lee, M.D., Ph.D.2, Young Lee, M.D., Ph.D., Chang Deok Kim, Ph.D., Jeung Hoon Lee, M.D., Ph.D. Department of Dermatology, College of Medicine, Chungnam National University, Daejeon, 1Skin Research Institute, Amorepacific R&D Center, Yongin, 2Lee Joong Hwa Urologic Clinic, Daejeon, Korea Background: Nkx2.5 is a homeodomain-containing nuclear -Keywords- transcription protein that has been associated with acute Keratinocyte differentiation, Nkx2.5, Transcription factor T-lymphoblastic leukemia. In addition, Nkx2.5 has an essential role in cardiomyogenesis. However, the expression of Nkx2.5 in the skin has not been investigated. Objective: INTRODUCTION In an attempt to screen the differentially regulated genes involved in keratinocyte differentiation, using a cDNA Keratinocytes provide the rigid stratified structure of the microarray, we identified Nkx2.5 as one of the transcription skin through a highly complicated and tightly regulated factors controlling the expression of proteins associated with process of differentiation1. Many differentiation-related keratinocyte differentiation. Methods: To investigate the genes, including those encoding transglutaminase 1 and 3 expression of Nkx2.5 during keratinocyte differentiation, we (TGase 1 and 3), involucrin, cornifin, loricrin, filaggrin, used a calcium-induced keratinocyte differentiation model. and small proline-rich proteins (SPRs), have been shown Results: RT-PCR and Western blot analysis revealed that the to be expressed in a temporally regulated manner during expression of Nkx2.5, in cultured human epidermal kerati- keratinocyte differentiation2-6.
    [Show full text]
  • The Cytogenetics of Hematologic Neoplasms 1 5
    The Cytogenetics of Hematologic Neoplasms 1 5 Aurelia Meloni-Ehrig that errors during cell division were the basis for neoplastic Introduction growth was most likely the determining factor that inspired early researchers to take a better look at the genetics of the The knowledge that cancer is a malignant form of uncon- cell itself. Thus, the need to have cell preparations good trolled growth has existed for over a century. Several biologi- enough to be able to understand the mechanism of cell cal, chemical, and physical agents have been implicated in division became of critical importance. cancer causation. However, the mechanisms responsible for About 50 years after Boveri’s chromosome theory, the this uninhibited proliferation, following the initial insult(s), fi rst manuscripts on the chromosome makeup in normal are still object of intense investigation. human cells and in genetic disorders started to appear, fol- The fi rst documented studies of cancer were performed lowed by those describing chromosome changes in neoplas- over a century ago on domestic animals. At that time, the tic cells. A milestone of this investigation occurred in 1960 lack of both theoretical and technological knowledge with the publication of the fi rst article by Nowell and impaired the formulations of conclusions about cancer, other Hungerford on the association of chronic myelogenous leu- than the visible presence of new growth, thus the term neo- kemia with a small size chromosome, known today as the plasm (from the Greek neo = new and plasma = growth). In Philadelphia (Ph) chromosome, to honor the city where it the early 1900s, the fundamental role of chromosomes in was discovered (see also Chap.
    [Show full text]
  • Viral Vectors Applied for Rnai-Based Antiviral Therapy
    viruses Review Viral Vectors Applied for RNAi-Based Antiviral Therapy Kenneth Lundstrom PanTherapeutics, CH1095 Lutry, Switzerland; [email protected] Received: 30 July 2020; Accepted: 21 August 2020; Published: 23 August 2020 Abstract: RNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro-RNA (miRNA) have demonstrated efficacy in gene silencing for therapeutic applications against viral diseases. Bioinformatics has played an important role in the design of efficient RNAi sequences targeting various pathogenic viruses. However, stability and delivery of RNAi molecules have presented serious obstacles for reaching therapeutic efficacy. For this reason, RNA modifications and formulation of nanoparticles have proven useful for non-viral delivery of RNAi molecules. On the other hand, utilization of viral vectors and particularly self-replicating RNA virus vectors can be considered as an attractive alternative. In this review, examples of antiviral therapy applying RNAi-based approaches in various animal models will be described. Due to the current coronavirus pandemic, a special emphasis will be dedicated to targeting Coronavirus Disease-19 (COVID-19). Keywords: RNA interference; shRNA; siRNA; miRNA; gene silencing; viral vectors; RNA replicons; COVID-19 1. Introduction Since idoxuridine, the first anti-herpesvirus antiviral drug, reached the market in 1963 more than one hundred antiviral drugs have been formally approved [1]. Despite that, there is a serious need for development of novel, more efficient antiviral therapies, including drugs and vaccines, which has become even more evident all around the world today due to the recent coronavirus pandemic [2].
    [Show full text]
  • Rapid Evolution of Mammalian X-Linked Testis-Expressed Homeobox Genes
    Copyright 2004 by the Genetics Society of America DOI: 10.1534/genetics.103.025072 Rapid Evolution of Mammalian X-Linked Testis-Expressed Homeobox Genes Xiaoxia Wang and Jianzhi Zhang1 Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, Michigan 48109 Manuscript received November 26, 2003 Accepted for publication February 11, 2004 ABSTRACT Homeobox genes encode transcription factors that function in various developmental processes and are usually evolutionarily conserved in their sequences. However, two X-chromosome-linked testis-expressed homeobox genes, one from rodents and the other from fruit flies, are known to evolve rapidly under positive Darwinian selection. Here we report yet another case, from primates. TGIFLX is an X-linked homeobox gene that originated by retroposition of the autosomal gene TGIF2, most likely in a common ancestor of rodents and primates. While TGIF2 is ubiquitously expressed, TGIFLX is exclusively expressed in adult testis. A comparison of the TGIFLX sequences among 16 anthropoid primates revealed a signifi- cantly higher rate of nonsynonymous nucleotide substitution (dN) than synonymous substitution (dS), strongly suggesting the action of positive selection. Although the high dN/dS ratio is most evident outside ف the homeobox, the homeobox has a dN/dS of 0.89 and includes two codons that are likely under selection. Furthermore, the rate of radical amino acid substitutions that alter amino acid charge is significantly greater than that of conservative substitutions, suggesting that the selection promotes diversity of the protein charge profile. More interestingly, an analysis of 64 orthologous homeobox genes from humans and mice shows substantially higher rates of amino acid substitution in X-linked testis-expressed genes than in other genes.
    [Show full text]